{
    "2018-08-22": [
        [
            {
                "time": "2018-08-23",
                "original_text": "关于核准上海医药集团股份有限公司向合格投资者公开发行公司债券的批复",
                "features": {
                    "keywords": [
                        "上海医药",
                        "公司债券",
                        "核准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-08-23",
                "original_text": "速读社丨阿斯利康肺癌新药Tagrisso日本获批 再鼎医药计划赴港上市",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "Tagrisso",
                        "再鼎医药",
                        "赴港上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-08-22",
                "original_text": "22日晚可能影响股价重要财经证券资讯速递",
                "features": {
                    "keywords": [
                        "股价",
                        "财经证券资讯"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-23",
                "original_text": "[增持评级]医药生物行业周报：调整行情下聚焦中报 持续关注业绩好、估值合理标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增持评级",
                        "中报",
                        "业绩",
                        "估值合理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-23",
                "original_text": "证监会：核准上海医药发行不超50亿元公司债",
                "features": {
                    "keywords": [
                        "证监会",
                        "上海医药",
                        "公司债",
                        "核准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-08-23",
                "original_text": "医药生物行业日报：河南调整多项医保政策",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保政策",
                        "河南"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-23",
                "original_text": "投资日报 | 区域医保控费龙头企业、中医诊疗智能系统开拓者等完成融资",
                "features": {
                    "keywords": [
                        "医保控费",
                        "龙头企业",
                        "中医诊疗",
                        "智能系统",
                        "融资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}